Fraiya
King's College London spin-out whose AI software supports fetal ultrasound by guiding image acquisition, automating biometry and detecting anomalies; trial results reported a 42% reduction in scan time, and the product holds CE marking under EU MDR with ISO 13485 certification.
Headquarters
London, United Kingdom
Year Founded
2024
Founders
Reza Razavi (co-founder and CEO), Jacqueline Matthew (co-founder)
Country
United Kingdom
Financial Information
Funding Stage
Pre-Seed
Recent Funding
GBP 3.5M
Funding By
RAW Ventures, Cedars-Sinai Ventures, NIHR i4i grant
Core Technology
AI models for fetal ultrasound acquisition guidance, biometry and anomaly detection
Product Type
Medical Device
Pipeline Stage (Very Important)
Regulatory Status
- IND Filed: N/A
- FDA/EMA Status: N/A
- Clinical Trial Registration: PROMETHEUS randomised trial of AI-assisted fetal ultrasound
- Patents / IP Status: Not disclosed
Partnerships
Pharma Collaborations
None disclosed
Academic / Hospital Tie-ups
King's College London; Guy's and St Thomas' NHS Foundation Trust
CRO/CDMO Partnerships
None disclosed
Market & Differentiation
Cuts scan time while improving measurement repeatability in fetal ultrasound